Newest publications

Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life. Magdalena Górny, Anna Bilska-Wilkosz, Małgorzata Iciek, Marta Hereta, Kinga Kamińska, Adrianna Kamińska, Grażyna Chwatko, Zofia Rogóż, Elżbieta Lorenc-Koci
Antioxidants (Basel, Switzerland), E538 10.3390/antiox9060538
PMID:32575563
Effect of combined treatment with aripiprazole and antidepressants on the MK-801-induced deficits in recognition memory in novel recognition test and on the release of monoamines in the rat frontal cortex. Marta Hereta, Kinga Kamińska, Magdalena Białoń, Agnieszka Wąsik, Elżbieta Lorenc-Koci, Zofia Rogóż
Behavioural brain research, S0166-4328(20)30468-X 10.1016/j.bbr.2020.112769
PMID:32535184
Impact of developmental origin, niche mechanics and oxygen availability on osteogenic differentiation capacity of mesenchymal stem/stromal cells. Natalia Bryniarska, Andrzej Kubiak, Anna Łabędź-Masłowska, Ewa Zuba-Surma
Acta biochimica Polonica, 10.18388/abp.2019_2893
PMID:31883439
More publications

Journal


Events


2nd article Open Access in Pharmacological Reports 2/2020 2nd article Open Access in Pharmacological Reports 2/2020
We strongly recommend reading an interesting article titled "Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration" published in Open Access (Pharmacological Reports 2/2020).
Institute of Pharmacology researchers awarded funding in National Science Centre Institute of Pharmacology researchers awarded funding in National Science Centre
We are pleased to inform that nine projects involving the Institute of Pharmacology researchers have been awarded funding in recent National Science Centre call for proposals (OPUS 18, SONATA 15 and PRELUDIUM 18).
Article Open Access in Pharmacological Reports 2/2020 Article Open Access in Pharmacological Reports 2/2020
We strongly recommend reading an interesting article titled "Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders" published in Open Access (Pharmacological Reports 2/2020).
Free access to all Covid-19 related research results Free access to all Covid-19 related research results
On March 13, the United States Office for Science and Technology Policy (OSTP) initiated a campaign which is supported by the National Science Advisors of 12 other countries. The request is to deposit all published articles (Version of Record) reporting on research results related to Covid-19 in the repositories of PubMed Central (PMC) and the World Health Organization (WHO). The campaign is asking to let researchers have free access, full reuse rights, and text and data mining (TDM) rights.
New date of the 4th CEBC congress New date of the 4th CEBC congress
Dear Chairpersons, Dear Participants of the 4th Central European Biomedical Congress, The Organizing Committee of 4th CEBC regretfully inform you about cancellation of this congress planned for 19-22 May 2020. This decision has been reached as an act of precaution against development of coronavirus (COVID-19). The health and safety of all of you constitute our top priority. The new date of the 4th CEBC congress is announced for 4-8 June 2021.
Article Open Access in Pharmacological Reports 1/2020 Article Open Access in Pharmacological Reports 1/2020
We strongly recommend reading an interesting article titled "New therapeutic strategies in nonalcoholic fatty liver disease: a focus on promising drugs for nonalcoholic steatohepatitis" published in Open Access (Pharmacological Reports 1/2020).
More News and Events